(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Instructions to Choose the Best Web based Advertising Degree Program for Your Objectives - 2The Manual for Electric Vehicles that will be hot dealers in 2023
- 3Tens of thousands protest as far-right AfD forms new youth group
- 4How to get tickets for AC/DC's 2026 'Power Up' Tour
- 5Vote In favor of Your Favored Web-based Venture Stage
- Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies
- Step by step instructions to Contrast Lab Jewels and Regular Ones
- Manual for Spending plan Agreeable PC
- 6 Hints to Upgrade Your Appeal, In addition to Your Outlook
- Flight cancellations: Full list of 40 airports hit by FAA cuts amid government shutdown
- Audits of 6 American Busssiness Class Flights
- Help Your Efficiency: 10 Authoritative Apparatuses to Attempt
- Wellness Bits of knowledge Readily available: A Survey of \Following Wellbeing and Progress\ Wellness Wearables
- The newest 'Project Hail Mary' trailer shows Ryan Gosling befriending an alien in Phil Lord and Chris Miller's space epic
